CYDX OTC
CYduct Diagnostics, Inc.
1W: +9.3%
1M: -57.3%
3M: +19.1%
YTD: +146.2%
1Y: +112.9%
3Y: +24.4%
5Y: -60.0%
$0.50
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$71K
-29.2% ▼
5Y CAGR: -18.3%
Gross Profit
$47K
-32.1% ▼
5Y CAGR: -18.7%
Operating Income
-$363K
+14.8% ▲
Net Income
-$414K
+11.6% ▲
EPS (Diluted)
$-0.08
+13.3% ▲
EBITDA
-$363K
+14.1% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $161K | $94K | $119K | $84K | $71K |
| YoY Growth | -17.3% | -41.5% | +26.9% | -29.2% | — |
| Cost of Revenue | $45K | $31K | $36K | $28K | $24K |
| Gross Profit | $116K | $64K | $83K | $57K | $47K |
| Gross Margin | 71.8% | 67.5% | 69.9% | 67.0% | 66.2% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $486K | $467K | $525K | $436K | $410K |
| Operating Expenses | $486K | $467K | $525K | $436K | $410K |
| Operating Income | -$371K | -$404K | -$445K | -$379K | -$363K |
| Operating Margin | -230.6% | -429.1% | -372.6% | -448.5% | -513.8% |
| Interest Expense | $1K | $17K | $31K | $39K | $50K |
| Income Before Tax | -$372K | -$420K | -$476K | -$418K | -$414K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$372K | -$420K | -$473K | -$418K | -$414K |
| Net Margin | -231.3% | -447.1% | -396.1% | -494.8% | -585.1% |
| EPS (Diluted) | $-0.07 | $-0.08 | $-0.09 | $-0.08 | $-0.08 |
| EBITDA | -$371K | -$167K | -$441K | -$379K | -$363K |
| Shares Outstanding | 5M | 5M | 5M | 5M | 5M |